Dietary Protein Sources and Atherogenic Dyslipidemia
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Insulin Resistance
Related studies linked through entity extraction aliases.
Caveolin-1 and Vascular Dysfunction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
- Status
- TERMINATED
- Phase
- PHASE2
Poznan Prospective Study of Type 1 Diabetic Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
- Status
- COMPLETED
- Phase
- NA
Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health
- Status
- COMPLETED
- Phase
- N/A
Effects of Sleep Duration and Architecture on Insulin Sensitivity
- Status
- COMPLETED
- Phase
- NA
Vitamin D and Glucose Metabolism in Pediatrics
- Status
- UNKNOWN
- Phase
- PHASE4
Vitamin D Replacement in Insulin Resistant South Asians
- Status
- TERMINATED
- Phase
- NA
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance
- Status
- COMPLETED
- Phase
- NA
The Effects of Orange Juice on Plasma Lipids
- Status
- COMPLETED
- Phase
- NA
Regional Fat Depots and Insulin Resistance
- Status
- COMPLETED
- Phase
- N/A
Hypovitaminosis D : A Link Between Bone/Mineral and Fat/Fuel Metabolism
- Status
- COMPLETED
- Phase
- PHASE3
Progressive Weight Loss and Metabolic Health
- Status
- COMPLETED
- Phase
- NA
Glycemic Load, Metabolism & Obesity in Pregnancy
- Status
- COMPLETED
- Phase
- NA
Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity
- Status
- COMPLETED
- Phase
- PHASE2